tiprankstipranks
Advertisement
Advertisement

AGIO Stock Latest News

Agios Pharmaceuticals Earnings Call Signals Strong Momentum
Company AnnouncementsAgios Pharmaceuticals Earnings Call Signals Strong Momentum
5d ago
AGIO
Agios Pharmaceuticals price target lowered to $36 from $39 at Truist
PremiumThe Fly
Agios Pharmaceuticals price target lowered to $36 from $39 at Truist
5d ago
AGIO
Agios Pharmaceuticals reports Q1 EPS ($1.69), consensus ($1.79)
PremiumThe Fly
Agios Pharmaceuticals reports Q1 EPS ($1.69), consensus ($1.79)
6d ago
AGIO
Is AGIO a Buy, Before Earnings?
PremiumPre-Earnings
Is AGIO a Buy, Before Earnings?
8d ago
AGIO
Agios Pharmaceuticals price target lowered to $41 from $44 at BofA
PremiumThe Fly
Agios Pharmaceuticals price target lowered to $41 from $44 at BofA
14d ago
NVO
AGIO
Maintaining Buy on Agios: Mitapivat’s Risk-Adjusted Upside Despite Etavopivat Competition and Regulatory Uncertainty
PremiumRatingsMaintaining Buy on Agios: Mitapivat’s Risk-Adjusted Upside Despite Etavopivat Competition and Regulatory Uncertainty
14d ago
AGIO
Agios Pharmaceuticals: Mitapivat’s Early-Mover Advantage and Diversified Pipeline Support Buy Rating Despite Emerging Sickle Cell Competition
Premium
Ratings
Agios Pharmaceuticals: Mitapivat’s Early-Mover Advantage and Diversified Pipeline Support Buy Rating Despite Emerging Sickle Cell Competition
15d ago
AGIO
H.C. Wainwright cuts Agios target on smaller market post Novo data
Premium
The Fly
H.C. Wainwright cuts Agios target on smaller market post Novo data
15d ago
NVO
AGIO
Agios Pharmaceuticals falls -23.4%
PremiumThe Fly
Agios Pharmaceuticals falls -23.4%
15d ago
AGIO
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
PremiumThe Fly
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
15d ago
BX
DX
Agios Pharmaceuticals falls -23.7%
PremiumThe Fly
Agios Pharmaceuticals falls -23.7%
15d ago
AGIO
Agios sinks after Novo Nordisk reports sickle cell data
PremiumThe Fly
Agios sinks after Novo Nordisk reports sickle cell data
15d ago
NVO
AGIO
Agios could come under pressure off Novo Nordisk headline, says Truist
PremiumThe FlyAgios could come under pressure off Novo Nordisk headline, says Truist
15d ago
NVO
AGIO
Agios Pharmaceuticals price target raised to $36 from $31 at JPMorgan
Premium
The Fly
Agios Pharmaceuticals price target raised to $36 from $31 at JPMorgan
29d ago
AGIO
Agios Pharmaceuticals price target raised to $36 from $31 at JPMorgan
Premium
The Fly
Agios Pharmaceuticals price target raised to $36 from $31 at JPMorgan
29d ago
AGIO
Agios Pharmaceuticals price target raised to $32 from $28 at Goldman Sachs
PremiumThe Fly
Agios Pharmaceuticals price target raised to $32 from $28 at Goldman Sachs
1M ago
AGIO
Leerink says Agios’ filing reinforces FDA flexibility ahead of Fulcrum update
PremiumThe Fly
Leerink says Agios’ filing reinforces FDA flexibility ahead of Fulcrum update
1M ago
AGIO
FULC
Agios Pharmaceuticals: Mitapivat’s Accelerated Approval Path and De-Risked Sickle Cell Opportunity Support Buy Rating
PremiumRatings
Agios Pharmaceuticals: Mitapivat’s Accelerated Approval Path and De-Risked Sickle Cell Opportunity Support Buy Rating
1M ago
AGIO
Agios up 13% at $33.50 after announcing pursuit of approval for mitapivat
PremiumThe Fly
Agios up 13% at $33.50 after announcing pursuit of approval for mitapivat
1M ago
AGIO
Agios Pharmaceuticals to pursue U.S. accelerated approval for mitapivat
PremiumThe FlyAgios Pharmaceuticals to pursue U.S. accelerated approval for mitapivat
1M ago
AGIO
Citi ups Agios target, opens ‘upside 90-day catalyst watch’
Premium
The Fly
Citi ups Agios target, opens ‘upside 90-day catalyst watch’
2M ago
AGIO
Agios Pharmaceuticals Pyrukynd approved for adults in UAE
Premium
The Fly
Agios Pharmaceuticals Pyrukynd approved for adults in UAE
2M ago
AGIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >